Provided by Tiger Trade Technology Pte. Ltd.

Scienture Holdings, Inc.

4.13
+0.37009.84%
Post-market: 4.10-0.0300-0.73%19:40 EDT
Volume:108.71K
Turnover:427.48K
Market Cap:6.78M
PE:-0.08
High:4.20
Open:3.85
Low:3.65
Close:3.76
52wk High:65.00
52wk Low:3.23
Shares:1.64M
Float Shares:1.28M
Volume Ratio:0.08
T/O Rate:8.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-50.7500
EPS(LYR):-67.6214
ROE:-53.47%
ROA:-8.93%
PB:0.11
PE(LYR):-0.06

Loading ...

Scienture Net Loss Narrows to $2.82 Million in Q2 FY26; Revenue Turns to $343,639

Reuters
·
Aug 14

Scienture Announces Commercial Launch and Fulfillment of Initial Purchase Orders of Rezenopy™, the Highest Dose FDA-Approved Naloxone Nasal Spray

THOMSON REUTERS
·
Aug 12

Scienture Holdings Inc Expected to Post a Loss of 23 Cents a Share - Earnings Preview

Reuters
·
Aug 07

When Will Scienture Holdings, Inc. (NASDAQ:SCNX) Become Profitable?

Simply Wall St.
·
Jul 27

Analysts Are Bullish on Top Healthcare Stocks: Scienture Holdings (SCNX), Royalty Pharma (RPRX)

TIPRANKS
·
Jul 10

Scienture Holdings Stock Jumps Over 20% Pre-Market: Here's Why

Benzinga
·
Jul 10

Scienture to begin shipments of Rezonopy to wholesalers

TIPRANKS
·
Jul 09

Scienture Holdings - to Begin July Shipments of Rezenopy Nasal Spray 10 Mg to U.S. Wholesalers

THOMSON REUTERS
·
Jul 09

SCIENTURE Announces Commercial Inventory Readiness and July Shipments of REZENOPY™ (naloxone hydrochloride) to Wholesalers

GlobeNewswire
·
Jul 09

Scienture announces progress in commercialization of Arbli

TIPRANKS
·
Jun 18

Scienture says large national health plan adds REZENOPY naloxone spray to formulary

Reuters
·
Jun 09

SCIENTURE Secures Formulary Coverage for REZENOPY™ with a Large National Health Plan and Expands Commercial Team

GlobeNewswire
·
Jun 09

Scienture wins US patent for REZENOPY naloxone nasal spray, protection through 2041

Reuters
·
Jun 02

Scienture Receives U.S. Patent Covering Rezenopy™ (Naloxone Hcl) Nasal Spray 10 Mg, Strengthening Intellectual Property Protection Through 2041

THOMSON REUTERS
·
Jun 02

SCIENTURE Receives U.S. Patent Covering REZENOPY™ (Naloxone HCl) Nasal Spray 10 mg, Strengthening Intellectual Property Protection Through 2041

GlobeNewswire
·
Jun 02

BRIEF-Scienture - Eric Sherb Resigns As CFO Effective May 26, 2026

Reuters
·
May 30

Scienture - Appoints Narasimhan Mani as Interim CFO Effective May 26, 2026 - SEC Filing

THOMSON REUTERS
·
May 30

Scienture names Narasimhan Mani interim CFO after Eric Sherb resigns

Reuters
·
May 30

Scienture Holdings Q1 revenue jumps on Arbli sales, operating expenses steady

Reuters
·
May 18

Scienture Reports First Quarter 2026 Financial Results and Business Update Highlighted by Significant Revenue Growth and Gross Margin Expansion

THOMSON REUTERS
·
May 18